Targeting siglec-E on murine dendritic cells inhibits antigen presentation and CD4 and CD8 t cell responses
Marieke Bax(Amsterdam UMC Location Vrije Universiteit Amsterdam), Yvette van Kooyk(Amsterdam University Medical Centers), Eiríkur Saeland(Janssen (Netherlands)), Manja Litjens(Utrecht University), Sandra J. van Vliet(Dutch Cancer Society), Satwinder Singh(Central University of Punjab), Emma McKenzie(Amsterdam UMC Location Vrije Universiteit Amsterdam), Wendy W. J. Unger(Erasmus MC), Paul R. Crocker(Memorial University of Newfoundland), Juan J. García‐Vallejo(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 1
Related Papers
Siglecs and their roles in the immune system
|Nature reviews. Immunology|2007|2k
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
|Cancer Cell|2020|683
C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB
|Immunity|2007|573
Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk
|Nature Immunology|2009|482
The tumour glyco-code as a novel immune checkpoint for immunotherapy
|Nature reviews. Immunology|2018|470